194 related articles for article (PubMed ID: 29897749)
21. Structure and reaction mechanism in the heme dioxygenases.
Efimov I; Basran J; Thackray SJ; Handa S; Mowat CG; Raven EL
Biochemistry; 2011 Apr; 50(14):2717-24. PubMed ID: 21361337
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.
Lu C; Lin Y; Yeh SR
J Am Chem Soc; 2009 Sep; 131(36):12866-7. PubMed ID: 19737010
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of indoleamine and tryptophan 2,3-dioxygenases: Comparative study on kynurenine pathway in cell lines via LC-MS/MS-based targeted metabolomics.
Villani S; Fallarini S; Rezzi SJ; Di Martino RMC; Aprile S; Del Grosso E
J Pharm Biomed Anal; 2024 Jan; 237():115750. PubMed ID: 37804639
[TBL] [Abstract][Full Text] [Related]
24. Binding of l-kynurenine to X. campestris tryptophan 2,3-dioxygenase.
Basran J; Booth ES; Campbell LP; Thackray SJ; Jesani MH; Clayden J; Moody PCE; Mowat CG; Kwon H; Raven EL
J Inorg Biochem; 2021 Dec; 225():111604. PubMed ID: 34571402
[TBL] [Abstract][Full Text] [Related]
25. Probing the ternary complexes of indoleamine and tryptophan 2,3-dioxygenases by cryoreduction EPR and ENDOR spectroscopy.
Davydov RM; Chauhan N; Thackray SJ; Anderson JL; Papadopoulou ND; Mowat CG; Chapman SK; Raven EL; Hoffman BM
J Am Chem Soc; 2010 Apr; 132(15):5494-500. PubMed ID: 20353179
[TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
27. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.
Thomas SR; Stocker R
Redox Rep; 1999; 4(5):199-220. PubMed ID: 10731095
[TBL] [Abstract][Full Text] [Related]
28. X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson's Disease.
Ning XL; Li YZ; Huo C; Deng J; Gao C; Zhu KR; Wang M; Wu YX; Yu JL; Ren YL; Luo ZY; Li G; Chen Y; Wang SY; Peng C; Yang LL; Wang ZY; Wu Y; Qian S; Li GB
J Med Chem; 2021 Jun; 64(12):8303-8332. PubMed ID: 34110158
[TBL] [Abstract][Full Text] [Related]
29. Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase.
Forouhar F; Anderson JL; Mowat CG; Vorobiev SM; Hussain A; Abashidze M; Bruckmann C; Thackray SJ; Seetharaman J; Tucker T; Xiao R; Ma LC; Zhao L; Acton TB; Montelione GT; Chapman SK; Tong L
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):473-8. PubMed ID: 17197414
[TBL] [Abstract][Full Text] [Related]
30. How is the distal pocket of a heme protein optimized for binding of tryptophan?
Chauhan N; Basran J; Rafice SA; Efimov I; Millett ES; Mowat CG; Moody PC; Handa S; Raven EL
FEBS J; 2012 Dec; 279(24):4501-9. PubMed ID: 23083473
[TBL] [Abstract][Full Text] [Related]
31. The ternary complex of PrnB (the second enzyme in the pyrrolnitrin biosynthesis pathway), tryptophan, and cyanide yields new mechanistic insights into the indolamine dioxygenase superfamily.
Zhu X; van Pée KH; Naismith JH
J Biol Chem; 2010 Jul; 285(27):21126-33. PubMed ID: 20421301
[TBL] [Abstract][Full Text] [Related]
32. Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase.
Lu C; Lin Y; Yeh SR
Biochemistry; 2010 Jun; 49(24):5028-34. PubMed ID: 20476772
[TBL] [Abstract][Full Text] [Related]
33. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
[TBL] [Abstract][Full Text] [Related]
34. Exploring the mechanism of tryptophan 2,3-dioxygenase.
Thackray SJ; Mowat CG; Chapman SK
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1120-3. PubMed ID: 19021508
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase.
Basran J; Booth ES; Lee M; Handa S; Raven EL
Biochemistry; 2016 Dec; 55(49):6743-6750. PubMed ID: 27951658
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
[TBL] [Abstract][Full Text] [Related]
37. High l-Trp affinity of indoleamine 2,3-dioxygenase 1 is attributed to two residues located in the distal heme pocket.
Yuasa HJ
FEBS J; 2016 Oct; 283(19):3651-3661. PubMed ID: 27522067
[TBL] [Abstract][Full Text] [Related]
38. Reassessment of the reaction mechanism in the heme dioxygenases.
Chauhan N; Thackray SJ; Rafice SA; Eaton G; Lee M; Efimov I; Basran J; Jenkins PR; Mowat CG; Chapman SK; Raven EL
J Am Chem Soc; 2009 Apr; 131(12):4186-7. PubMed ID: 19275153
[TBL] [Abstract][Full Text] [Related]
39. Methylene blue and ascorbate interfere with the accurate determination of the kinetic properties of IDO2.
Yuasa HJ; Stocker R
FEBS J; 2021 Aug; 288(16):4892-4904. PubMed ID: 33686747
[TBL] [Abstract][Full Text] [Related]
40. Ligand migration in human indoleamine-2,3 dioxygenase.
Nienhaus K; Nickel E; Lu C; Yeh SR; Nienhaus GU
IUBMB Life; 2011 Mar; 63(3):153-9. PubMed ID: 21445845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]